tirzepatide clinical trial enrollment Tirzepatide: A Systematic Update Tirzepatide shows 47% greater weight

The comparative effectiveness of an expanded 2-year on-treatment analysis that followed patients who stay on the exposure or comparator therapies for a prolonged time showed concordant results with the 1-year on-treatment analysis (Supplementary Table 25)

You should see a doctor if you experience any new or worsening vision changes, such as: blurred vision dark spots flashes of light sudden vision loss For people without diabetes or without existing eye disease, eye-related side effects are considered very unlikely

References Akbar, A

Avoid high-fat or spicy foods

You're trading the benefits of clinical testing and consistent manufacturing for better access

Clinical Trial Registration ClinicalTrials.gov: NCT04235959